Non Small Cell Lung Cancer Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
N
Recruiting
  • Endocrine/Neuroendocrine
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2022-04-07
Apr 7, 2022
L
Recruiting
  • Non-Small Cell Lung Cancer
  • Berazategui, Buenos Aires, Argentina
  • +206 more
2022-04-06
Apr 6, 2022
S
Active, not recruiting
  • Non-small Cell Lung Cancer
  • sintilimab
  • +3 more
  • Hangzhou, Zhejiang, China
    Second Affiliated Hospital, School of Medicine, Zhejiang Univers
2022-04-06
Apr 6, 2022
C
Active, not recruiting
  • Non-Small Cell Lung Cancer
  • Baltimore, Maryland
  • +5 more
2022-04-07
Apr 7, 2022
N
Recruiting
  • Endocrine Tumors
  • +5 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2022-04-07
Apr 7, 2022
M
Active, not recruiting
  • Non-small Cell Lung Cancer
  • ALT-803
  • Nivolumab
  • Weston, Florida
  • +3 more
2022-03-30
Mar 30, 2022
T
Not yet recruiting
  • Non-Small Cell Lung Cancer
  • Observation
  • (no location specified)
2022-04-07
Apr 7, 2022
D
Active, not recruiting
  • Non-small Cell Lung Cancer
  • Phoenix, Arizona
  • +81 more
2022-04-07
Apr 7, 2022
L
Recruiting
  • Non-Small Cell Lung Cancer
  • Chemoradiotherapy
  • Chemoradiotherapy with Integrated Boost Dose
  • London, Ontario, Canada
  • +6 more
2022-04-07
Apr 7, 2022
N
Recruiting
  • Multiple Myeloma
  • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    2022-04-07
    Apr 7, 2022
    N
    Recruiting
    • Non-Small Cell Lung Cancer
    • +4 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      2022-04-07
      Apr 7, 2022
      N
      Enrolling by invitation
      • Melanoma
      • +4 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center, 9000 Rockville Pi
        2022-04-07
        Apr 7, 2022
        E
        Completed
        • Advanced Cancer
        • +5 more
        • Los Angeles, California
        • +7 more
        2022-04-07
        Apr 7, 2022
        A
        Recruiting
        • Non-Small Cell Lung Cancer
        • Small Cell Lung Cancer
        • Tucson, Arizona
        • +18 more
        2022-04-06
        Apr 6, 2022
        W
        Not yet recruiting
        • Non Small Cell Lung Cancer
        • Non-small Cell Lung Cancer
          • Atlanta, Georgia
          • +6 more
          2022-03-29
          Mar 29, 2022
          B
          Recruiting
          • Neoplasm Metastasis
          • Non-Small Cell Lung Cancer
          • BI 1810631
          • Dallas, Texas
          • +4 more
          2022-04-06
          Apr 6, 2022
          C
          Terminated
          • Non-small Cell Lung Cancer
          • Shanghai, Shanghai, China
            No. 241 Huaihai West Road, Xuhui District, Shanghai
          2022-03-29
          Mar 29, 2022
          N
          Recruiting
          • Pancreatic Cancer
          • +15 more
          • Grand Rapids, Michigan
          • +2 more
          2022-04-05
          Apr 5, 2022
          M
          Recruiting
          • Non-Small Cell Lung Cancer
          • Sotorasib and Tarloxotinib
          • Charleston, South Carolina
            Hollings Cancer Center at Medical University of South Carolina
          2022-03-28
          Mar 28, 2022